DCL News
December 2009
Medical Update: ACOG announces changes in cervical cancer screening guidelines 
: Recommendations include screening beginning at age 21, co-testing (Pap+HPV) for ages 30 and older
May 2009
DCL first in Midwest to perform FDA approved HPV Genotyping
March 16, 2009
DCL Medical Laboratories introduces Reveal Cx™
Breakthrough diagnostic test in risk assessment for cervical cancer
assists physicians in providing individualized care
